Exonics Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Exonics Therapeutics, Inc. - overview
Established
2017
Location
Watertown, MA, US
Primary Industry
Biotechnology
About
Founded in 2017 and based in Massachusetts, US, Exonics Therapeutics, Inc. operates as a biotechnology company that focuses on developing SingleCut CRISPR, a gene repair technology for the treatment of neuromuscular diseases.
Current Investors
CureDuchenne Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.exonicstx.com
Verticals
HealthTech
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Exonics Therapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.